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Of the many mysteries that surround the brain, few surpass the awe-inspiring complexity of its development. The intricate wiring of the brain at both the system and molecular level is both spatially and temporally regulated in perfect synchrony. How such a delicate, yet elegant, system arises from an embryo's most basic cells remains at the forefront of neuroscientific research. At the cellular level, the competitive dance between synapses struggling to gain dominance seems to be refereed by both neurons themselves and microglia, the innate immune cells of the nervous system. Additionally, the unexpected complement cascade, a major effecter arm of the innate immune system, is almost certainly involved in synaptic remodeling by tagging destined neurons and synapses for destruction. As suddenly as they appear, the mechanisms of neurogenesis recede entering into adulthood. However, with age and insult, these mechanisms boisterously return, resulting in neurodegeneration. This review describes some of the mechanisms involved in synaptogenesis and wiring of the brain from the point of view of the innate immune system and then covers how similar molecular processes return with age and disease, specifically in the context of Alzheimer's disease.
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Introduction
Classically, the brain has been deemed an absolute immune privileged organ, due in part to the tight junction laden epithelial cells that line the cerebrovasculature, constituting the aptly named blood brain barrier (BBB). This concept, however, has begun to wane with the observations of infiltrating macrophages and T cells during BBB breakage. However, even with an intact BBB, neurons, astrocytes and resident microglia express a full range of immune markers including major histocompatability complexes (MHC), toll-like receptors (TLR), cytokines and their receptors and components of the complement cascade. This evidence suggests that in a normal state, the CNS modulates its own 'neuroimmune' system and thus its immune privilege state is only relative to other organs (Galea et al., 2007) . This provides a second line of defense against infiltrating microbes and a clean up mechanism for maintaining the brain parenchyma.
Additionally, recent evidence has suggested a role for microglia, the brain's resident immune cells, in synaptic development and maintenance through neuron-microglia interactions and complement-mediated mechanisms. Through unexpected means, microglia have the ability to influence wiring at the synaptic level and thus aid in the control of learning and memory.
On the other hand, this newly recognized function of the immune system can have detrimental effects on the delicate architecture of the brain as seen in many neurodegenerative diseases. Observations in the field of neuroinflammation suggest an intricate homeostatic balance between neurons and immune cells that if tipped either way, leads to neuronal dysfunction and cognitive deterioration. This has become a highly researched area within the realm of the most common form of dementia, Alzheimer's disease (AD), where complement activation and microglial dysfunction seem to contribute significantly to disease onset and progression. If left unchecked, the mechanisms of microglia-mediated synaptic development described above can be pushed in a direction of pathological alteration of synapses and the surrounding brain milieu.
The wide array of functions and their effect on nervous system development and disease has sparked a massive interest into the cellular and molecular dynamics of the immune system residing within the walls of the BBB. This review will encompass these mechanisms in terms of microglial function in the developing brain and how dysfunction of this resident immune network leads to neurodegenerative diseases such as Alzheimer's disease. We will also discuss the dichotomy of complement cascade function in development and neurodegenerative disease and
